Statistics

Total Visits

Views
Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS assessed both in tumor and blood sample, as a marker of response to enzalutamide in patients with metastatic castration resistant prostate cancer (CRPC) pre-chemotherapy73

Select a period of time:

Number of views in the range

Views
Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS assessed both in tumor and blood sample, as a marker of response to enzalutamide in patients with metastatic castration resistant prostate cancer (CRPC) pre-chemotherapy21

Views

Views
August 20259
September 20256
October 20253
November 20251
December 20252
January 20260
February 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil9
United Kingdom4
United States3
South Africa2
Ecuador1
Hungary1
Mexico1
 

Top cities views

Views
Johannesburg2
Belo Horizonte1
Canoas1
Chapecó1
Cristalina1
Curitiba1
Dallas1
García1
Pé de Serra1
Quito1